Molecular genetic diagnosis of biallelic PKHD1 mutations was previously known in 18 patients described here and newly identified in a further 20 patients from a total of 30 different families, giving an overall mutation detection rate of 94% in our cohort of clinically suspected ARPKD (Table 2). This evidence concerns the gene PKHD1 and autosomal recessive polycystic kidney disease.